AVBP compared with CMPX: revenue, margins and what each company keeps, and the suppliers and customers both name

AVBPArriVent BioPharma, Inc.

Mkt capRevenueRevenue

CMPXCompass Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

AVBPArriVent BioPharma, Inc.

CMPXCompass Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AVBP 8

—Shanghai Allist Pharmaceuticalsunlistedsupplier

—Lepu Biopharmaunlistedsupplier

—Aarvik Therapeuticsunlistedsupplier

—Jiangsu Alphamab Biopharmaceuticalsunlistedsupplier

4 more · AVBP chain ›

Shared 0

No shared counterparties.

Only CMPX 5

—ABL Biounlistedsupplier

—Adimabunlistedsupplier

—B. Riley Securitiesunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

—

Elpiscience Biopharmaceuticals

unlistedsupplier

1 more · CMPX chain ›

AVBPArriVent BioPharma, Inc.

13.93▼−6.31%

Mkt cap$707.9MRevenue—

CMPXCompass Therapeutics, Inc.

0.77▼−2.28%

Regular sessionNov 2 '26

Mkt cap$141.6MRevenue$850,000Q2 FY24

Compare

Regular sessionNov 2 '26

AVBPArriVent BioPharma, Inc.

CMPXCompass Therapeutics, Inc.

13.93▼−6.31%

Price

0.77▼−2.28%

$707.9M

Mkt cap

$141.6M

—

Revenue

$850,000Q2 FY24

AVBP13.93▼−6.31%vsCMPX0.77▼−2.28%Regular sessionNov 2 '26